ISOLATE-SPECIFIC NEUTRALIZING ANTIBODIES IN PATIENTS WITH PROGRESSIVE HIV-1-RELATED DISEASE

被引:70
作者
VONGEGERFELT, A
ALBERT, J
MORFELDTMANSON, L
BROLIDEN, K
FENYO, EM
机构
[1] KAROLINSKA INST,DEPT INFECT DIS,S-10401 STOCKHOLM 60,SWEDEN
[2] NATL BACTERIOL LAB,DEPT VIROL,S-10521 STOCKHOLM,SWEDEN
关键词
D O I
10.1016/0042-6822(91)90764-3
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Four individuals with increasing severity of HIV-1 infection were studied for serum neutralizing activity against their own virus isolates collected during 1-3 years. Sequential serum samples and HIV-1 isolates were available from these patients from the stage of lymphadenopathy to severe immunodeficiency. The replicative capacity of isolates changed from slow/low to rapid/high in each patient during the study period. Sequential virus isolates showed differences in sensitivity to neutralization by autologous as well heterologous area. Taken together with our previous results demonstrating that variant viruses resistent to neutralization by autologous sera emerge during the year following primary infection, neutralization-resistent variants seem to emerge during the entire course of HIV-1 infection. The ability to produce neutralizing antibodies to autologous virus appears to correlate with replicative capacity of the virus and the degree of immunodeficiency in the patient. © 1991.
引用
收藏
页码:162 / 168
页数:7
相关论文
共 27 条
[1]   RAPID DEVELOPMENT OF ISOLATE-SPECIFIC NEUTRALIZING ANTIBODIES AFTER PRIMARY HIV-1 INFECTION AND CONSEQUENT EMERGENCE OF VIRUS VARIANTS WHICH RESIST NEUTRALIZATION BY AUTOLOGOUS SERA [J].
ALBERT, J ;
ABRAHAMSSON, B ;
NAGY, K ;
AURELIUS, E ;
GAINES, H ;
NYSTROM, G ;
FENYO, EM .
AIDS, 1990, 4 (02) :107-112
[2]  
ASJO B, 1986, LANCET, V2, P660
[3]   NATURALLY-OCCURRING HIV-1 ISOLATES WITH DIFFERENCES IN REPLICATIVE CAPACITY ARE DISTINGUISHED BY INSITU HYBRIDIZATION OF INFECTED-CELLS [J].
ASJO, B ;
SHARMA, UK ;
MORFELDTMANSON, L ;
MAGNUSSON, A ;
BARKHEM, T ;
ALBERT, J ;
OLAUSSON, E ;
VONGEGERFELT, A ;
LIND, B ;
BIBERFELD, P ;
FENYO, EM .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (10) :1177-1182
[4]  
ASJO B, 1987, J VIROL, V157, P359
[5]   PREDICTIVE MARKERS OF AIDS - A FOLLOW-UP OF LYMPHOCYTE SUBSETS AND HIV SEROLOGY IN A COHORT OF PATIENTS WITH LYMPHADENOPATHY [J].
BOTTIGER, B ;
MORFELDTMANSON, L ;
PUTKONEN, P ;
NILSSON, B ;
JULANDER, I ;
BIBERFELD, G .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1989, 21 (05) :507-514
[6]   BIOLOGIC FEATURES OF HIV-1 THAT CORRELATE WITH VIRULENCE IN THE HOST [J].
CHENGMAYER, C ;
SETO, D ;
TATENO, M ;
LEVY, JA .
SCIENCE, 1988, 240 (4848) :80-82
[7]  
FENYO EM, 1988, J VIROL, V62, P4414
[8]   BIOLOGICAL SIGNIFICANCE OF THE ANTIBODY-RESPONSE TO HIV ANTIGENS EXPRESSED ON THE CELL-SURFACE [J].
GOUDSMIT, J ;
LJUNGGREN, K ;
SMIT, L ;
JONDA, M ;
FENYO, EM .
ARCHIVES OF VIROLOGY, 1988, 103 (3-4) :189-206
[9]  
HO DD, 1985, NEW ENGL J MED, V312, P649, DOI 10.1056/NEJM198503073121015
[10]   SERUM ENHANCEMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION CORRELATES WITH DISEASE IN HIV-INFECTED INDIVIDUALS [J].
HOMSY, J ;
MEYER, M ;
LEVY, JA .
JOURNAL OF VIROLOGY, 1990, 64 (04) :1437-1440